MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1705339 CAUSEWAY BAY, K3

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$76,771,388

-$651,165 QoQ

Shares Held

171,925

+0.7% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,370,693 across 239 Biotechnology names. VRTX ranks #1 (17.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	171,925	$76,771,388
2	REGN	Regeneron Pharmaceuticals, Inc.	69,854	$53,971,993
3	ALNY	Alnylam Pharmaceuticals, Inc.	81,325	$26,908,001
4	INSM	INSMED Inc	122,958	$20,106,091
5	RPRX	Royalty Pharma plc	419,129	$20,105,617
6	PRAX	Praxis Precision Medicines, Inc.	27,744	$8,938,838
7	ARWR	Arrowhead Pharmaceuticals, Inc.	139,598	$8,752,793
8	MRNA	Moderna, Inc.	147,589	$7,497,520

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$76,771,388	171,925	+0.7%	Shares	Defined	2026-05-15
2025-12-31	$77,422,553	170,775	+2.9%	Shares	Defined	2026-02-17
2025-09-30	$64,990,698	165,945	-24.4%	Shares	Defined	2025-11-14
2025-06-30	$97,691,571	219,433	-7.5%	Shares	Defined	2025-08-14
2025-03-31	$115,011,424	237,225	+25.3%	Shares	Defined	2025-05-15
2024-12-31	$76,215,000	189,260	+0.3%	Shares	Defined	2025-02-14
2024-09-30	$87,757,339	188,693	-3.2%	Shares	Defined	2024-11-14
2024-06-30	$91,332,434	194,855	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.